Thomas J. Schall - Mar 11, 2024 Form 3 Insider Report for Immuneering Corp (IMRX)

Role
Director
Signature
/s/ Michael D. Bookman, Attorney-in-Fact for Thomas J. Schall
Stock symbol
IMRX
Transactions as of
Mar 11, 2024
Transactions value $
$0
Form type
3
Date filed
3/12/2024, 08:31 AM
Previous filing
Oct 24, 2022
Next filing
Mar 25, 2024

No securities are beneficially owned.